Guided Therapeutics (GTHP) Minority Interest (2010 - 2012)
Guided Therapeutics recorded quarterly Minority Interest of $104000.0 in Q3 2012, little changed quarter-over-quarter from $104000.0 in Q2 2012.
Guided Therapeutics' Minority Interest history runs 3 years deep, the most recent figure standing at $104000.0 for Q3 2012.
- In Q3 2012, Minority Interest changed N/A year-over-year to $104000.0; the TTM figure through Sep 2012 stood at $104000.0 (changed N/A YoY), while the FY2011 annual figure was $104000.0, changed 0.0% from the prior year.
- Minority Interest came in at $104000.0 for Q3 2012 at Guided Therapeutics, roughly flat from $104000.0 in the prior quarter.
- In the past five years, Minority Interest ranged from a high of $104000.0 in Q4 2010 to a low of $104000.0 in Q4 2010.
- A 3-year average of $104000.0 and a median of $104000.0 in 2010 frame the typical range for Minority Interest.
- On a YoY basis, Minority Interest climbed as much as 0.0% in 2011 and fell as far as 0.0% in 2011.
- Guided Therapeutics' Minority Interest stood at $104000.0 in 2010, then changed by 0.0% to $104000.0 in 2011, then changed by 0.0% to $104000.0 in 2012.
- According to Business Quant data, Minority Interest over the past three periods registered $104000.0, $104000.0, and $104000.0 for Q3 2012, Q2 2012, and Q1 2012 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Guided Therapeutics | - | - | 458,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2012 | 104,000.00 |
| Jun 30, 2012 | 104,000.00 |
| Mar 31, 2012 | 104,000.00 |
| Dec 31, 2011 | 104,000.00 |
| Dec 31, 2010 | 104,000.00 |